Program – 65th Days H.P. Klotz – 2023
Program updated 04/12/2023.
THURSDAY 25 MAY 2023
ENDOCRINE DISORDERS CAUSED BY IMMUNE CHECK-POINT INHIBITORS (ICPI)
Chairs : Pr Lionel Groussin & Pr Olivier Chabre
9:15-9:45 am Pathophysiological mechanism of ICPI-Induced endocrine disorders
Dr Jean-Marie Michot, Paris
9:45 – 10:15 am Pituitary and adrenal disorders
Dr Frédérique Albarel, Marseille, France
10:15 – 10:45 am Thyroid disorders
Dr Frédéric Illouz, CHU d’Angers
10:45 – 11:15 am Diabetes mellitus
Pr Bruno Vergès, CHU de Dijon
Break with poster session and exhibition visit
(11:15-11:45 am)
OPIOID IATROGENY
Chair : Pr Philippe Chanson
11:45 – 12:15 am Opioid iatrogeny on endocrine glands
Pr Niki Karavitaki, CHU Birmingham, Angleterre
Break lunch
(12h15-13h30)
IATROGENIC DIABETE AND METABOLIC SYNDROME
Chairs : Pr Marie-Christine Vantyghem & Pr Yves Reznik
1:30 – 2:00 pm Metabolic complications of Glucocorticoids, metformin efficacy
Pr Marta Korbonits, London
2:00 – 2:30 pm Clinical management of glucorticoid-induced diabetes
Pr Vincent Rigalleau, CHU Bordeaux
2:30 – 3:00 pm Metabolic disorders induced by psychotropic drugs
Pr André Scheen, CHU Liège, Belgique
Break with poster session and exhibition visit
(3:00 – 3:30 pm)
ARTIFICIAL ENDOCRINE DISORDERS
Chairs : Pr Dominique Maiter & Pr Luca Persani
3:30 – 4:00 pm Factitious Hypoglycemia
Dr Thierry Galvez, Dr Manuela Lotierzo, CHU Montpellier
4:00 – 4:30 pm Factitious Thyrotoxicosis
Pr Luca Persani, Milan, Italie
4:30 – 5:00 pm Factitious Cushing
Pr Olivier Chabre, CHU Grenoble
IATROGENIC DISORDERS OF BONE METABOLISM
Chairs : Dr Véronique Raverot & Pr Marie-Christine Vantyghem
5:00 – 5:30 am Bone damage by glucorticoids
Pr Bernard Cortet, CHU de Lille
5:30 – 6:00 am Bone fragility in endocrine disorders (adrenal, thyroid, gonade, parathyroid, diabetes, acromegaly…)
Dr Karine Briot, CHU Cochin, Paris
FRIDAY 26 MAY 2023
CHEMOTHERAPY INDUCED ENDOCRINE DISORDERS
Chairs : Pr Sophie Christin-Maitre & Pr Patrice Rodien
9h00 – 9h30 am Thyrosine kinase inhibitors
Dr Simone De Leo, Milan
9h30 – 10:00 am Chemotherapies and male fertility
Dr Ingrid Plotton, Lyon
10:00 – 10:30 am Chemotherapies and female fertility
Dr Charlotte Sonigo, Hopital Antoine-Beclere, Clamart
ORAL COMMUNICATION
10:35 – 10:40 am An unknown cause of persistent impaired ovarian function: long-term Mitotane exposure for adrenal cortical carcinoma: Successful fertility management with in vitro maturation of oocytes and late recovery of ovarian function.
Hélène Bry-Gauillard
Break with poster session and exhibition visit
(10h40-11h00)
THYROID, ADRENAL AND PITUITARY IATROGENY
Chairs : Pr Albert Beckers & Pr Bernard Corvilain
11:00 – 11:30 pm Hyperprolactinemia
Pr Philippe Chanson, CHU Kremlin Bicetre, Paris
11:30 – 12:00 pm SIADH
Pr Jean Philippe Haymann, Hopital Tenon, Paris
ORAL COMMUNICATION
12:00 – 12:05 pm Oxidative stress, autophagy on the testes of immature hyperthyroid rats
Lynda LAKABI
12:05 – 12:10 pm Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer (ACC) Patients: Prevalence and Timeline
Jonathan Poirier
DÉJEUNER / Break lunch
(12h10-13h30)
THYROID, ADRENAL AND PITUITARY IATROGENY
Chairs : Pr Albert Beckers & Pr Bernard Corvilain
1:30 – 2:00 pm Lithium-INDUCED endocrine alterations
Pr Marie-Christine Vanthygem, CHRU Lille
2:30 – 3:00 pm Pseudo-phéochromocytoma
Pr Hervé Lefebvre, CHU de Rouen
STEROIDS IATROGENY
Chairs : Pr Philippe Touraine & Pr Yves Reznik
3:00 – 3:30 pm Tissue impact and detection
Pr Jacques-François Young, CHU Kremlin Bicetre, Paris
3:30 – 4:00 pm Progestatives and meningiomas
Pr Geneviève Plu Bureau, CHU Cochin, Paris
4:00 pm : Closing Remarks and End of Congress